SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-021580
Filing Date
2022-01-28
Accepted
2022-01-28 16:06:33
Documents
5
Effectiveness Date
2022-01-28

Document Format Files

Seq Description Document Type Size
1 S-8 d235379ds8.htm S-8 77805
2 EX-5.1 d235379dex51.htm EX-5.1 8740
3 EX-23.1 d235379dex231.htm EX-23.1 2103
4 GRAPHIC g235379dsp1a.jpg GRAPHIC 11225
5 GRAPHIC g235379snap0003.jpg GRAPHIC 3548
  Complete submission text file 0001193125-22-021580.txt   110164
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262392 | Film No.: 22568814
SIC: 2834 Pharmaceutical Preparations